Effect of SMS 201-995 on exocrine pancreatic secretion in a patient with external pancreatic fistula

International Journal of Pancreatology

Volumn 11, Issue 3, 1992, Pages 185-189

  Ohta, Tetsuo ^a   Nagakawa, Takukazu ^a   Mori, Kazuhiro ^a   Kanno, Masahiro ^a   Kayahara, Masato ^a   Ueno, Keiichi ^a   Miyazaki, Itsuo ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

A long acting somatostatin analog; inhibition of pancreatic exocrine function; SMS 201 995 (Sandostatin )

Indexed keywords

AMYLASE; BICARBONATE; OCTREOTIDE; PROTEIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; PANCREAS FISTULA; PANCREAS FUNCTION; PANCREAS SECRETION; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TEST MEAL; TOTAL PARENTERAL NUTRITION;

FEMALE; HUMAN; MIDDLE AGE; OCTREOTIDE; PANCREAS; PANCREATIC FISTULA;

EID: 0026701529     PISSN: 01694197     EISSN: 15590739     Source Type: Journal    
DOI: 10.1007/BF02924184     Document Type: Review

References (21)

1. A new management for the complete disruption of the pancreatojejunostomy following pancreatoduodenectomy
2. A very potent and selective octapeptide analog of somatostatin with prolonged action
3. Effect of the somotostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men
4. Effects of SMS 201-995, a somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in dogs
5. A comparison of the effects of two somatostatin analogues in a patient with an external pancreatic fistula
6. Inhibition by somatostatin of secretin-stimulated pancreatic secretion in man: A study with pure pancreatic juice
7. Effect of octreotide acetate on pancreatic exocrine function
8. Improvement technique for pancreatico- jejunostomy after extended pancreaticoduodenectomy
9. The hormones of hypothalamus
10. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
11. Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas
12. Effect of 24-hours somatostatin infusion on glucose homeostasis and on levels of somatostatin, pancreatic and thyroid hormones in man
13. Inhibition of gastrin and gastric acid secretion by growth hormone releasing- inhibiting hormone (GH-RIH)
14. Somatostatin supresses secretin and pancreatic exocrine secretion
15. Effect of somatostatin on myoelectrical activity of small bowel
16. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin
17. The use of somatostatin and its analogues in the treatment of surgical disorders
18. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201-995
19. Treatment of patients with pancreatic endocrine tumors using a new long-acting somatostatin analogue
20. Multicenter clinical trial of SMS 201-995 in gastroenteropancreatic endocrine tumors
21. Effects of SMS 201-995, long-acting somatostatin analogue, on the exocrine pancreatic secretion and gut hormone release in rats